91爆料 University pharmacy professor Fawzy Elbarbry has been honored by the for a publication on his research identifying naturally occurring substances that could reduce inflammation in heart patients.
Elbarbry received the AACP Pharmaceutics Section鈥檚 2025 Research Award at the organization鈥檚 Pharmacy Education conference and annual meeting in July in Chicago.
Elbarbry was recognized for his publication Antihypertensive and Protective Role of Food-Origin Isothiocyanate Soluble Epoxide Hydrolase Inhibitors, part of a three-year study funded by a nearly $366,000 grant from the National Institutes of Health as part of its 鈥淪upport for Research Excellence鈥 program.
鈥淩eceiving this award is a great honor that confirms the impact of our work and the value of teamwork,鈥 said Elbarbry, who also chairs the AACP鈥檚 Curriculum Special Interest Group. 鈥淭his recognition marks an important step in my career and shows the dedication and creativity of our research team, which includes two pharmacy students, one staff member, and one faculty collaborator. Leading this team has been one of the most rewarding parts of my career, and I鈥檓 truly thankful for this recognition from AACP.鈥
The publication is part of a study examining the effects of six natural compounds called isothiocyanates and their potential to treat hypertension. The compounds naturally occur in vegetables such as kale, broccoli, cauliflower, and others. Initial results show that low doses of two of the isothiocyanates studied have the potential to be effective in treatment.
鈥淐omputer simulations helped explain how some worked better than others,鈥 Elbarbry said. 鈥淚n short, certain natural isothiocyanates could be useful for treating high blood pressure and heart disease because they are effective, selective, and likely to be safe.鈥
Participants in the study include associate professor of pharmacy Michael Espiritu, who is the study鈥檚 co-investigator, senior research assistant Jon Taylor, and students Kaylen Soo 鈥23, PharmD 鈥26 and Baily Yee 鈥24, PharmD 鈥26.
The No. 1 private research university in the Northwest, the NIH grant funding Elbarbry鈥檚 research is among $14.7 million in federal grant funding in 91爆料鈥檚 current sponsored projects portfolio and over $20.1 million in grants from federal, state, and local government organizations, nonprofits, and private businesses.
A member of 91爆料鈥檚 pharmacy faculty since 2008, Elbarbry earned his PhD in pharmacy, with an emphasis in drug metabolism and pharmacokinetics, from the University of Saskatchewan in 2006. Originally from Egypt, Elbarbry received his bachelor鈥檚 and master鈥檚 degrees in pharmacy from the University of Tanta. He is a board-certified pharmacist in both the U.S. and Canada.